The forecast for the import of Heparin for therapeutic use to the Philippines shows a declining trend. Starting from 440.22 Thousand US Dollars in 2024, the value is expected to drop steadily to 402.56 Thousand US Dollars by 2028. This downward trend indicates a consistent year-on-year reduction, with a noticeable average decline rate.
When analyzing the variations year-on-year:
- 2024 to 2025: -2.21%
- 2025 to 2026: -2.20%
- 2026 to 2027: -2.22%
- 2027 to 2028: -2.18%
The Compound Annual Growth Rate (CAGR) over these years (2024-2028) results in an average annual decrease of approximately -2.20%.
Future trends to watch for:
- Changes in global supply and demand dynamics for Heparin.
- Potential for regulatory changes affecting import/export policies.
- Advances in alternative therapies or medicines that may impact Heparin usage.
- Economic factors influencing healthcare budgets and expenditure in the Philippines.
